(Q52719758)

6 May 2018

title

Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. (English)

1 reference

6 May 2018

Adam S Kibel

1 reference

6 May 2018

author name string

Matthew Mossanen

1 reference

6 May 2018

Steven L Chang

1 reference

6 May 2018

Simon Kimm

1 reference

6 May 2018

Guru P Sonpavde

1 reference

6 May 2018

publication date

1 May 2018

1 reference

6 May 2018

Urologic Clinics of North America

published in

1 reference

6 May 2018

volume

1 reference

6 May 2018

issue

1 reference

6 May 2018

page(s)

143-154

1 reference

6 May 2018

Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The value of a second transurethral resection for T1 bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The value of a second transurethral resection in evaluating patients with bladder tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Diagnostic dilemmas in patients with upper tract urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

CT urography for hematuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

64-Slice CT urography: 30 months of clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The role of computed tomography in the staging of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Bladder cancer diagnosis: the role of CT urography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Advances in bladder cancer imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Bladder cancer: can imaging change patient management?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Imaging of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Urinary bladder cancer: role of MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

New imaging modalities in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Dynamic MRI of bladder cancer: evaluation of staging accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Utility of diffusion-weighted MRI in the diagnosis of bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Diffusion-weighted MR imaging in diagnosis of superficial and invasive urinary bladder carcinoma: a preliminary prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Diffusion-weighted MRI in the body: applications and challenges in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

MR imaging of the male pelvis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

FDG-PET for preoperative staging of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Age-stratified distribution of metastatic sites in bladder cancer: A population-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Management of bone metastases in prostate cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Utilisation of preoperative imaging for muscle-invasive bladder cancer: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Whole-body MR imaging: evaluation of patients for metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Functional magnetic resonance imaging in oncology: state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Variations in Preoperative Use of Bone Scan Among Medicare Beneficiaries Undergoing Radical Cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Metastatic Pattern of Bladder Cancer: Correlation With the Characteristics of the Primary Tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Pulmonary nodules: detection, assessment, and CAD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Clinical value of FDG PET or PET/CT in urinary bladder cancer: A systemic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The role of lymphadenectomy in high-grade invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

Risk of chronic kidney disease after cancer nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2017.12.001

10.1016/J.UCL.2017.12.001

7 January 2021

Identifiers

DOI

1 reference

6 May 2018

1 reference

6 May 2018